1338 related articles for article (PubMed ID: 26242280)
61. fim3-24/ptxP-3 genotype is associated to whooping cough outbreak in Brazilian Midwest: The selection of Bordetella pertussis strains driven by vaccine immunization.
de Paula VG; de Sousa RS; da Silva RCMR; Alves EG; Caetano AR; Ianella P; de Campos TA
Infect Genet Evol; 2024 Jul; 121():105599. PubMed ID: 38679113
[TBL] [Abstract][Full Text] [Related]
62. Evolution of whooping cough bacterium may reduce vaccine effectiveness.
Riedmann EM
Hum Vaccin Immunother; 2014; 10(6):1430. PubMed ID: 25396233
[No Abstract] [Full Text] [Related]
63. [Investigation of seropositivity of Bordetella pertussis in adults in a university hospital].
Öksüz L; Gürler N; Ağaçfidan A
Mikrobiyol Bul; 2017 Jan; 51(1):62-72. PubMed ID: 28283011
[TBL] [Abstract][Full Text] [Related]
64. Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study.
Zouari A; Smaoui H; Brun D; Njamkepo E; Sghaier S; Zouari E; Félix R; Menif K; Ben Jaballah N; Guiso N; Kechrid A
Diagn Microbiol Infect Dis; 2012 Apr; 72(4):303-17. PubMed ID: 22313629
[TBL] [Abstract][Full Text] [Related]
65. Surveillance of pertussis in the CSSR. IV. Immunological surveys of antibodies to pertussis and parapertussis in the Bohemian regions and in Slovakia in 1958 - 1971.
Vysoká-Burianová B; Burian V; Maixnerová M; Prásilová K; Kríz B; Wernish Z; Zikmundová V; Kavanová M; Tĕmínová J; Richter J; Stehlik J; Paroulek J; Formánek J; Stejskalová M; Bezecná A; Bäumlová M; Zofka J; Strnad P; Zusková D; Zácek K
J Hyg Epidemiol Microbiol Immunol; 1976; 20(2):229-47. PubMed ID: 184206
[No Abstract] [Full Text] [Related]
66. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.
Bart MJ; Harris SR; Advani A; Arakawa Y; Bottero D; Bouchez V; Cassiday PK; Chiang CS; Dalby T; Fry NK; Gaillard ME; van Gent M; Guiso N; Hallander HO; Harvill ET; He Q; van der Heide HG; Heuvelman K; Hozbor DF; Kamachi K; Karataev GI; Lan R; Lutyńska A; Maharjan RP; Mertsola J; Miyamura T; Octavia S; Preston A; Quail MA; Sintchenko V; Stefanelli P; Tondella ML; Tsang RS; Xu Y; Yao SM; Zhang S; Parkhill J; Mooi FR
mBio; 2014 Apr; 5(2):e01074. PubMed ID: 24757216
[TBL] [Abstract][Full Text] [Related]
67. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.
Geurtsen J; Fae KC; van den Dobbelsteen GP
Expert Rev Vaccines; 2014 Oct; 13(10):1229-40. PubMed ID: 25081731
[TBL] [Abstract][Full Text] [Related]
68. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
[No Abstract] [Full Text] [Related]
69. Complement evasion by Bordetella pertussis: implications for improving current vaccines.
Jongerius I; Schuijt TJ; Mooi FR; Pinelli E
J Mol Med (Berl); 2015 Apr; 93(4):395-402. PubMed ID: 25686752
[TBL] [Abstract][Full Text] [Related]
70. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
[TBL] [Abstract][Full Text] [Related]
71. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?].
Cofré J
Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113
[TBL] [Abstract][Full Text] [Related]
72. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
73. A profile of the Simplexa™ Bordetella Direct assay for the detection and differentiation of
Dominguez DC
Expert Rev Mol Diagn; 2020 Sep; 20(9):889-894. PubMed ID: 32885709
[TBL] [Abstract][Full Text] [Related]
74. Pertussis control: time for something new?
Clark TA; Messonnier NE; Hadler SC
Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
[TBL] [Abstract][Full Text] [Related]
75. Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.
Knowles K; Lorange M; Matthews RC; Preston NW
Can Commun Dis Rep; 1993 Nov; 19(21):182-3, 186-7. PubMed ID: 8298581
[No Abstract] [Full Text] [Related]
76. Improving pertussis vaccination.
Berbers GA; de Greeff SC; Mooi FR
Hum Vaccin; 2009 Jul; 5(7):497-503. PubMed ID: 19242096
[No Abstract] [Full Text] [Related]
77. The importance of herd immunity against infection.
Pigott N; Novelli V; Pooboni S; Firmin R; Goldman A
Lancet; 2002 Aug; 360(9333):645. PubMed ID: 12241962
[No Abstract] [Full Text] [Related]
78. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
Gillard J; van Schuppen E; Diavatopoulos DA
Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
[TBL] [Abstract][Full Text] [Related]
79. Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. A preliminary report to the Director of the Public Health Laboratory service by the Public Health Laboratory Service Whooping-Cough Committee and Working Party.
Br Med J; 1969 Nov; 4(5679):329-33. PubMed ID: 4318320
[TBL] [Abstract][Full Text] [Related]
80. Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection.
Wirsing von König CH; Finger H
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):455-8. PubMed ID: 7957264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
